Skip to main content
Consumer site
KenvuePro Logo

Tolerability

ZYRTEC® is generally well tolerated by children¹

Pediatric Clinical Data Tolerability

 In studies of children ages 6 to 11 years:

  • 4.2% of patients taking ZYRTEC® 10 mg reported somnolence (n=215) vs 1.3% with placebo (n=309)1

  • ≤1% of ZYRTEC® patients discontinued due to somnolence1

Tolerability: Discontinuation Due to Somnolence in Clinical Trials of Children Ages 6 to 111

Pediatric Clinical Data Tolerability Chart



Reference:

1. Data on file, Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division.